Health insurance shares moved sharply lower in premarket trading after Elevance Health’s (NYSE:ELV) latest quarterly results revealed continued pressure on margins within its core Health Benefits business, raising concerns that similar challenges could affect the wider managed-care sector.
Margin weakness overshadows earnings beat
Although Elevance reported second-quarter earnings and revenue that comfortably exceeded analysts’ expectations, investors focused on the deterioration in profitability.
The company’s adjusted operating margin declined to 3.6% from 5.0% a year earlier, sending Elevance shares down 6.7% in premarket trading.
The Health Benefits division, Elevance’s largest business, recorded a sharp drop in operating profit as lower Medicaid reimbursement rates and ongoing changes to its Medicare Advantage portfolio weighed on margins.
Sector peers come under pressure
The results triggered broad selling across the health insurance industry ahead of UnitedHealth Group’s (NYSE:UNH) own quarterly earnings release.
UnitedHealth shares fell 2.7% in premarket trading as investors worried that the margin pressure seen at Elevance could reflect broader industry trends.
Molina Healthcare (NYSE:MOH), which has significant exposure to Medicaid, dropped as much as 9%, marking the steepest decline among major managed-care providers.
Humana (NYSE:HUM) fell around 1.7%, while Centene (NYSE:CNC) declined 4.9% and CVS Health (NYSE:CVS) lost 2.3%.
Strong headline results mask underlying challenges
Elevance reported second-quarter revenue of 50.47 billion dollars, up 2.1% from a year earlier and comfortably ahead of analyst expectations.
Adjusted earnings per share came in at 7.45 dollars, significantly above the consensus forecast of 6.21 dollars.
The company also raised its full-year adjusted earnings guidance to at least 27.00 dollars per share.
However, investors noted that reported earnings benefited from an 0.80 dollar per-share non-operating gain, meaning underlying profitability was weaker than headline figures suggested.
Medicaid and Medicare continue to weigh on performance
The company’s Health Benefits segment experienced a substantial decline in operating profit as reimbursement rates failed to keep pace with rising medical costs, while the ongoing repositioning of its Medicare Advantage business also weighed on earnings.
Management had previously described 2026 as a transition year for the division, and the latest results reinforced those expectations.
Analysts also pointed to slowing membership growth, with total members declining to 44.95 million during the second quarter from 45.42 million in the previous quarter, although revenue per member continued to improve.
After a strong share price recovery earlier this year, the latest results have raised fresh questions about whether margin pressures could continue across the managed-care industry.
Elevance Health stock price
UnitedHealth Group stock price
Molina Healthcare stock price
Humana stock price
Centene stock price
CVS Health stock price
